CAS 790299-79-5 appears in our catalog under these names: Masitinib, 98%, Masitinib, >95% (HPLC), Masitinib/ 99.91% (existing batch purity), Masitinib (AB1010), Masitinib, >95.0%(HPLC)(T). Offered by: Combi-blocks, TRC, TargetMol, GLPBio, TCI. Available pack sizes: 1g, 250mg, 100mg, 10mg, 5mg, 50mg, 200mg, 25mg.
Masitinib is a member of the class of benzamides that is the carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary amino group of 4-methyl-N3-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]benzene-1,3-diamine. It is a highly selective oral tyrosine kinase inhibitor. It has a role as an antineoplastic agent, an antirheumatic drug and a tyrosine kinase inhibitor. It is a member of benzamides, a member of pyridines, a member of 1,3-thiazoles and a N-alkylpiperazine.
Source: ChEBI
| Molecular formula | C28H30N6OS |
|---|---|
| Molecular weight | 498.6 g/mol |
| IUPAC name | 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide |
| InChIKey | WJEOLQLKVOPQFV-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5 |
Computed by PubChem (NCBI)